Experimental study demonstrates ultra-narrowband UVA1 light emission using europium-activated fluoride phosphors, indicating strong potential to optimize clinical phototherapy devices.
UVA1 phototherapy has been recognised for its therapeutic benefits. A narrow-band UV source should prove more effective for phototherapy. In this work, we describe the fabrication of a narrow-band UVA1 LED based on a commercially available 275 nm UVB chip and a KMgF3:Eu2+ or K2LiAlF6:Eu2+ phosphor. The fabricated LED shows line emission with a maximum at 358 nm and a compressed width of 5 nm, whereas the emission from an LED available in the market (Roithner, xsl-360-se) extends over a relatively wide range with a full width at half maximum of about 15 nm. Such sources have the potential to revolutionise UVA1 therapy.
No takes yet. Share an insight, caveat, or question.
Nafdey et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: